In the News

201 News Items found
Andrea Cercek, a medical oncologist in MSK’s Gastrointestinal Service, speaking to a patient.
Feature
Learn more from Andrea Cercek about a new study showing that colorectal cancer rates are increasing in younger people.
Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at MSK
A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.
microscope image of regulatory T cells
A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.
coffee cup surrounded by beans
Ask the Expert
Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.
Cartoon of different-color heads with speaker and thought bubbles above them.
Feature
Even the most common cancers have aspects that are not fully grasped by the public.
Memorial Sloan Kettering medical oncologist Andrea Cercek
In the Clinic
A new treatment is approved for an especially aggressive kind of colorectal cancer.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
Amy Speck
Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Feature
MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
Image of liver with tumors
In the Clinic
A retrospective study from MSK has found that colorectal cancer patients with liver metastases live an average of two years longer when they receive an additional treatment called hepatic arterial infusion (HAI).